Ventricular fibrillations treatment
"ventricular fibrillation"[MeSH Terms] AND "defibrillation"[MeSH Terms]
ventricular fibrillation ECG waveform defibrillation treatment algorithm

This diagnostic image shows a single-lead electrocardiogram (ECG/EKG) strip plotted on standard red grid paper, demonstrating Ventricular Fibrillation (VF). The waveform is characterized by a chaotic, irregular, and disorganized rhythm. Key morphological features include the complete absence of identifiable P waves, QRS complexes, and T waves. The tracing displays fibrillatory waves with varying amplitudes and erratic vertical deflections, indicating a lack of coordinated ventricular contraction. The amplitude of these oscillations fluctuates, generally ranging across two small grid squares relative to the isoelectric baseline. This tracing is a classic representation of a shockable cardiac arrest rhythm, emphasizing the medical importance of rapid defibrillation in Advanced Cardiovascular Life Support (ACLS) protocols. It serves as a pedagogical tool for medical students and healthcare professionals to differentiate between organized rhythms and life-threatening ventricular arrhythmias.

This diagnostic image displays a series of six representative 5-second electrocardiogram (ECG) waveform segments (labeled a-f) illustrating the progression of ventricular fibrillation (VF) over time. The segments correspond to 1, 4, 6, 8, 10, and 12 minutes post-VF induction. Initially (1 min), the waveform shows high-amplitude, coarse VF with disorganized but rapid electrical activity. From 4 to 10 minutes, there is a visible trend toward 'fine' ventricular fibrillation, characterized by a progressive decrease in both amplitude and dominant frequency as the myocardium becomes increasingly ischemic and depleted of ATP. At 10 minutes (panel e), the rhythm is near-isoelectric with very low amplitude. However, at 12 minutes (panel f), following the initiation of oxygenated blood perfusion, there is a stark morphological shift back to high-amplitude, high-frequency coarse VF. This sequence demonstrates the clinical significance of myocardial oxygenation and metabolic state in influencing VF morphology and the potential for successful defibrillation (often correlated with AMSA—Amplitude Mid-frequency Spectrum Analysis).

This diagnostic image is a continuous rhythm strip (ECG trace) illustrating ventricular fibrillation, a life-threatening cardiac arrhythmia. The waveform is characterized by rapid, chaotic, and disorganized electrical activity. There is a total absence of identifiable P waves, QRS complexes, and T waves. The baseline is highly irregular, showing undulating oscillations with variable amplitudes and frequencies, consistent with the coarse ventricular fibrillation pattern. Annotated labels 'Initial Rhythm' and 'Point 1' indicate specific chronological markers during the clinical event recorded by emergency medical services. This tracing serves as a classic educational example of a shockable cardiac arrest rhythm requiring immediate defibrillation. It highlights the loss of coordinated ventricular contraction and the resulting hemodynamic collapse associated with this arrhythmia.

Multi-panel physiological waveform series demonstrating hemodynamic changes during ventricular fibrillation (VF) and subsequent defibrillation in the context of a continuous-flow left ventricular assist device (CF-LVAD). The image consists of a grid with six time-sequenced panels (A-F) tracking four parameters: Flow rates (PF: Pump Flow in pink, PAF: Pulmonary Artery Flow in cyan), Pressures (LVP: Left Ventricular Pressure in green, AOP: Aortic Pressure in purple), Central Venous Pressure (CVP in dark blue), and Electrocardiogram (ECG in red). Panels B-E illustrate the progression of sustained VF over 60 minutes, characterized by disorganized ECG activity and a compensatory increase in CVP amplitude and baseline (rising from ~10 to 14 mmHg). During VF, LVP and AOP remain significantly depressed with low pulsatility. Panel F displays the hemodynamic recovery post-defibrillation, showing the restoration of organized QRS complexes on ECG, a return of high-amplitude rhythmic pulsatility in LVP/AOP, and a significant reduction in CVP toward a stable baseline, signifying successful conversion to sinus rhythm and restored biventricular output.
"ventricular fibrillation" AND "cardiac arrest" AND treatment


| Drug | Dose | Notes |
|---|---|---|
| Amiodarone (first-line) | 300 mg IV push, then 150 mg if needed | Class III antiarrhythmic; lowers defibrillation threshold |
| Lidocaine (alternative) | 1-1.5 mg/kg IV; repeat 0.5-0.75 mg/kg every 5-10 min (max 3 mg/kg) | Use if amiodarone unavailable or contraindicated |
| Magnesium sulfate | 1-2 g IV | Only for torsades de pointes or hypomagnesemia-associated VF |
| Condition | Treatment |
|---|---|
| Polymorphic VT/VF + Acute Coronary Syndrome | Lidocaine, emergent PCI/coronary revascularization |
| Torsades de Pointes (acquired long QT) | Magnesium 1-2 g IV, transvenous pacing, isoproterenol |
| Brugada Syndrome / Idiopathic VF | Isoproterenol, quinidine |
| Hyperkalemia-induced VF | Calcium gluconate, sodium bicarbonate |
| WPW-related VF | Avoid AV nodal blockers; electrical cardioversion |
| Hypothermia | Active rewarming; VF may be refractory until core temp >30°C |